Greens Want European Parliament Funding for Homeopathy
by Green/EFA Group
April 13, 2005
The Greens and the European Free Alliance
in the European Parliament have called for a stronger
homeopathy presence in Europe and urged the Commission to fund
research into alternative medicine in the next framework programme.
On 10 April, the International Day for Homeopathy that marks
the 250th birthday of the German doctor Samuel Hahnemann, the
founder of homeopathy, the Green/EFA Group released a
statement criticising the official disregard in Europe for
homeopathy and calling for political action to stop the
'discrimination against alternative medicine in Europe'.
'The development of homeopathy in Europe, America and Asia is
a success story. However, while the interest of patients
continues to grow, authorities are lagging behind, sometimes
disregarding the potential of homeopathy and, sometimes
actively working against it,' stated Monica Frassoni,
Co-President of the Greens/EFA Group. 'We need political
action to stop this discrimination, especially as patients
want free choice of therapy.'
According to the group, homeopathy has proven its safety and
efficacy over more than two centuries and makes a significant
contribution to safeguarding public health. Yet, while
European directives state that veterinary homeopathy has a
prime place in organic farming, European and national
legislation work to restrict the access and availability of
those medicines by exaggerated safety standards, believes Ms
Frassoni.
'This is not in line with the new approach of 'Healthier
Living' which is on the top of the EU's health agenda,' the
statement added. 'Advocates of 'school medicine' often claim
that the efficacy of homeopathy has not been proven by
scientific studies. However, almost no public funding is
invested into research of complementary and alternative
medicine. This should be overcome by the next Framework
Programme for Research and Development launch,' she concluded.
FP7 Seventh Framework Programme for
Research and Technological Development
Objectives: The broad
policy objectives for the seventh RTD framework programme
(FP7) have been outlined in the Commission communication of 16
June 2004, COM(2004)353, 'Science and technology, the key to
Europe's future - Guidelines for future European Union policy
to support research'.
The RTD framework programmes group EU research and innovation
activities and FP7 will be the main financial instrument to
support research and technological development activities
starting from 2007. The objective of FP7 is to foster
scientific excellence, competitiveness and innovation both in
the EU and in non-EU countries (especially candidate
countries).
The seventh framework programme is also a
way to implement the European Research Area, the ultimate goal
of which is the gradual integration of European research at
local, regional, national and international level.